Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 3,000 shares at $12.74 ($38K) on 2018-11-23, disclosed to the SEC on 2018-11-26.
Scheduled sale ($38k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |